Michael G Oefelein

Title: Michael G Oefelein: Innovator in Bladder Cancer Treatment

Introduction

Michael G Oefelein is a notable inventor based in Bakersfield, California. He has made significant contributions to the field of medical formulations, particularly in the treatment of bladder cancer. His innovative work has led to the development of a unique patent that addresses critical needs in cancer therapy.

Latest Patents

Oefelein holds a patent for "Formulations for treating bladder cancer." This patent discloses compositions and methods for creating proliposomal and liposomal formulations of chemotherapeutic agents. These formulations are designed to be used in treatment regimens for bladder cancer and urothelial cancer. The invention includes a taxane, such as paclitaxel or docetaxel, or cisplatin, along with specific phospholipids. The formulations can be administered intravesically, making them suitable for treating bladder cancers effectively.

Career Highlights

Throughout his career, Oefelein has worked with various organizations, including Western University of Health Sciences and Tesorx Pharma, LLC. His experience in these institutions has contributed to his expertise in developing innovative cancer treatments.

Collaborations

Oefelein has collaborated with notable professionals in his field, including Guru V Betageri and Natarajan Venkatesan. These collaborations have further enhanced his research and development efforts in cancer treatment formulations.

Conclusion

Michael G Oefelein is a distinguished inventor whose work in bladder cancer treatment has the potential to improve patient outcomes significantly. His innovative formulations represent a crucial advancement in the fight against cancer.